ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Avon, NABCO Accepting Grant Applications For Community-Based Breast Cancer Programs

June 9, 1995

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

Three Cooperative Groups To Combine Statistical Center Operations

July 2, 2010

In Brief: Blumberg to direct NASA Astrobiology Institute’ Hopkins To Get $20M Donation

May 28, 1999

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001